PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsneurocysticercosis
MeSH D020019 - neurocysticercosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020809:Central nervous system helminthiasis
0 Companies
0 Drugs
Success rate
D003551:Cysticercosis
2 Companies
1 Drug
$
Success rate
D020019: 
Neurocysticercosis
10 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Alembic PharmaceuticalsAlbendazole Albendazole  2024-09-04   
AllerganAlbendazole Albendazole  2019-05-20   
Chartwell PharmaceuticalsAlbendazole Albendazole  2020-06-10   
CiplaAlbendazole Albendazole  2018-09-21   
Dr Reddys LaboratoriesAlbendazole Albendazole  2021-01-26   
Edenbridge PharmaceuticalsAlbendazole Albendazole  2019-05-14   
Impax LaboratoriesAlbendazole Albenza  1996-06-11   
MSN LaboratoriesAlbendazole Albendazole  2021-01-21   
Strides Pharma GlobalAlbendazole Albendazole  2018-12-07   
Zydus TherapeuticsAlbendazole Albendazole  2018-12-14   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
100%
4/4
Phase 3
33%
2/6
Approved: 1Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use